Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;17(4):e011445.
doi: 10.1161/CIRCHEARTFAILURE.123.011445. Epub 2024 Apr 6.

Qualitative Analysis of Patient Decisional Needs for Medications to Treat Heart Failure

Ricky D Turgeon  1   2 , Saranee Fernando  1   2 , Marc Bains  3 , Jillianne Code  1   3 , Nathaniel M Hawkins  1 , Sheri Koshman  4 , Lynn Straatman  1 , Mustafa Toma  1 , Sean A Virani  1 , Blair J MacDonald  1 , M Elizabeth Snow  1   2
Affiliations

Qualitative Analysis of Patient Decisional Needs for Medications to Treat Heart Failure

Ricky D Turgeon et al. Circ Heart Fail. 2024 Apr.

Abstract

Background: The development of tools to support shared decision-making should be informed by patients' decisional needs and treatment preferences, which are largely unknown for heart failure (HF) with reduced ejection fraction (HFrEF) pharmacotherapy decisions. We aimed to identify patients' decisional needs when considering HFrEF medication options.

Methods: This was a qualitative study using semi-structured interviews. We recruited patients with HFrEF from 2 Canadian ambulatory HF clinics and clinicians from Canadian HF guideline panels, HF clinics, and Canadian HF Society membership. We identified themes through inductive thematic analysis.

Results: Participants included 15 patients and 12 clinicians. Six themes and associated subthemes emerged related to HFrEF pharmacotherapy decision-making: (1) patient decisional needs included lack of awareness of a choice or options, difficult decision timing and stage, information overload, and inadequate motivation, support and resources; (2) patients' decisional conflict varied substantially, driven by unclear trade-offs; (3) treatment attribute preferences-patients focused on both benefits and downsides of treatment, whereas clinicians centered discussion on benefits; (4) quality of life-patients' definition of quality of life depended on pre-HF activity, though most patients demonstrated adaptability in adjusting their daily activities to manage HF; (5) shared decision-making process-clinicians' described a process more akin to informed consent; (6) decision support-multimedia decision aids, virtual appointments, and primary-care comanagement emerged as potential enablers of shared decision-making.

Conclusions: Patients with HFrEF have several decisional needs, which are consistent with those that may respond to decision aids. These findings can inform the development of HFrEF pharmacotherapy decision aids to address these decisional needs and facilitate shared decision-making.

Keywords: angiotensins; heart failure; informed consent; motivation; quality of life.

PubMed Disclaimer

Conflict of interest statement

Disclosures None.

Figures

Figure.
Figure.
Major themes and subthemes emerging from the qualitative analysis of patient and clinician interviews. HF indicates heart failure; QoL, quality of life; and SDM, shared decision-making.
See this image and copyright information in PMC

Comment in

References

    1. Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats A. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2022;118:cvac013. doi: 10.1093/cvr/cvac013 - PubMed
    1. McDonald M, Virani S, Chan M, Ducharme A, Ezekowitz JA, Giannetti N, Heckman GA, Howlett JG, Koshman SL, Lepage S, et al. . CCS/CHFS heart failure guidelines update: defining a new pharmacologic standard of care for heart failure with reduced ejection fraction. Can J Cardiol. 2021;37:531–546. doi: 10.1016/j.cjca.2021.01.017 - PubMed
    1. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, et al. . 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2022;79:e263–e421. doi: 10.1016/j.jacc.2021.12.012 - PubMed
    1. Writing C, Maddox TM, Januzzi JL, Allen LA, Breathett K, Butler J, Davis LL, Fonarow GC, Ibrahim NE, Lindenfeld J, et al. . 2021 update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the American college of cardiology solution set oversight committee. J Am Coll Cardiol. 2021;77:772–810. doi: 10.1016/j.jacc.2020.11.022 - PubMed
    1. Wu J-R, Moser DK, Lennie TA, Burkhart PV. Medication adherence in patients who have heart failure: a review of the literature. Nurs Clin North Am. 2008;43:133–153;vii–viii. doi: 10.1016/s1053-2498(01)00298-4 - PubMed

LinkOut - more resources